Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hively Brad
Director at Starling Oncology. Filing since 13 Nov 2023.
CIK 0001891124
Company
Date
Role
Action
Shares
Amount
Of holding
STLN
Starling Oncology, Inc.
21 Aug 2026
Director
Sold on a plan
298,853
$1.95M
42.0%
STLN
Starling Oncology, Inc.
15 Dec 2025
Director
Sold at will
13,333
$50.29K
1.9%
STLN
Starling Oncology, Inc.
19 Aug 2025
Director
Sold at will
20,221
$82.10K
3.1%
STLN
Starling Oncology, Inc.
3 Jun 2025
Director
Sold at will
1,976,137
$5.67M
76.6%
STLN
Starling Oncology, Inc.
26 Mar 2025
Director
Bought
9,056
$9.43K
1.4%
STLN
Starling Oncology, Inc.
2 Dec 2024
Director
Bought
50,000
$7.50K
8.1%
STLN
Starling Oncology, Inc.
26 Nov 2024
Director
Bought
250,000
$42.50K
68.2%
STLN
Starling Oncology, Inc.
17 Nov 2023
Director
Sold at will
25,000
$56.00K
3.5%
STLN
Starling Oncology, Inc.
13 Nov 2023
Director
Sold at will
47,000
$118.58K
6.1%
9 decisions on file.
